Envoy Medical, Inc.
COCH· Nasdaq
COCHEnvoy Medical, Inc.
Quarterly figures for Envoy Medical, Inc., with source filings when available.
22 quarters. Mar 31, 2021 to Jun 30, 2026. USD.
Envoy Medical, Inc. has filed its 10-Q within 31 to 45 days of period end across its last 8 quarters. The 10-K runs 82 to 93 days.
Envoy Medical, Inc. · CIK 1840877 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 10, 2026 · after-hours | Aug 10, 2026 | 41 d | 10-Q | $51.00K | −34.6% | -$0.07 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 11, 2026 · market hours |
| May 11, 2026 |
| 41 d |
| 10-Q |
| $39.00K |
| −15.2% |
| -$0.08 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | — | Mar 23, 2026 | 82 d | 10-K | $75.00K | +78.6% | — | |
| Q3 2025 | Sep 30, 2025 | Nov 10, 2025 · market hours | Nov 10, 2025 | 41 d | 10-Q | $42.00K | −25.0% | -$0.35 | |
| Q2 2025 | Jun 30, 2025 | Jul 31, 2025 · market hours | Jul 31, 2025 | 31 d | 10-Q | $78.00K | +14.7% | -$0.32 | |
| Q1 2025 | Mar 31, 2025 | May 1, 2025 · after-hours | May 1, 2025 | 31 d | 10-Q | $46.00K | −22.0% | -$0.29 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Mar 31, 2025 · market hours | Mar 31, 2025 | 90 d | 10-K | $42.00K | −55.8% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 · market hours | Nov 14, 2024 | 45 d | 10-Q | $56.00K | −30.0% | -$0.39 | |
| Q2 2024 | Jun 30, 2024 | Aug 12, 2024 · market hours | Aug 12, 2024 | 43 d | 10-Q | $68.00K | +7.9% | -$0.29 | |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 · after-hours | May 15, 2024 | 45 d | 10-Q | $59.00K | −24.4% | -$0.41 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | — | Apr 1, 2024 | 92 d | 10-K | $95.00K | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 17, 2023 | 48 d | 10-Q | $80.00K | +40.4% | $0.13 | |
| Q2 2023 | Jun 30, 2023 | — | Aug 14, 2023 | 45 d | 10-Q | $63.00K | — | -$1.31 | |
| Q1 2023 | Mar 31, 2023 | — | May 15, 2023 | 45 d | 10-Q | $78.00K | — | -$1.31 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | — | Apr 3, 2023 | 93 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | $57.00K | — | -$0.13 | |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | — | — | — | |
| Q1 2022 | Mar 31, 2022 | — | May 16, 2022 | 46 d | 10-Q | — | — | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | — | Mar 31, 2022 | 90 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | — | — | — | |
| Q2 2021 | Jun 30, 2021 | — | Aug 18, 2021 | 49 d | 10-Q | — | — | — | |
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | — | — | — | |
